To view the key comments of this regulatory directive please click on Summary of Key Comments to PRO2010-06 and PMRA Responses
Pest Management Regulatory Agency
27 February 2012
ISSN: 1498-5926 (PDF version)
Catalogue number: H113-3/2012-1E-PDF (PDF version)
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Pest control products can be registered in Canada only if their use poses no unacceptable risks to human health or the environment and has value. As with all pest control products, Health Canada's Pest Management Regulatory Agency (PMRA) further reduces any risks that pesticides may pose through policies that encourage the development and implementation of innovative, sustainable pest management strategies.
On 28 October 2010, the PMRA published for consultation Regulatory Proposal PRO2010-06 Guidelines for the Registration of Non-Conventional Pest Control Products. Comments received from stakeholders were considered in establishing this Regulatory Directive. Since first piloting the PRO2007-02, Guidelines for the Registration of Low-Risk Biochemicals and Non-Conventional Pesticides, approaches have been refined in consideration of comments received from government, industry and grower groups, and from insights gained during the pilot. The revised approach recognizes that non-conventional products may not fit well into a registration framework that was developed for 'conventional' pesticides with well defined chemistries and molecular structures.
The varied nature of these types of products can make it challenging to define a specific mode of action, to identify the active components of a mixture or to delineate a specific level of efficacy/value. This directive outlines a regulatory approach for non-conventional products with favourable risk profiles that allows innovation and flexibility assessing whether they have value and whether they pose any unacceptable risks to human health or the environment.
A wide range of non-conventional pest control products may be considered for review under this directive. Certain biopesticide products (microbials, semiochemicals and pheromones) have unique information requirements, as outlined in Regulatory Proposal PRO2002-02, Guidelines for the Research and Registration of Pest Control Products Containing Pheromones and Other Semiochemicals and Regulatory Directive DIR2001-02, Guidelines for the Registration of Microbial Pest Control Agents and Products. This regulatory directive does not replace these documents.
Products eligible for consideration under this directive must have some, but not necessarily all, of the following characteristics:
Substances eligible for review under this directive could include, but are not limited to:
The PMRA will assess the eligibility of products for review under this directive on the basis of all the evidence available. Applicants should submit a detailed rationale explaining why they believe their product is eligible for review under this directive. This should include details of the proposed use pattern and label claims, and as much scientific evidence as possible on the characterization of the components, toxicity, exposure and environmental fate.
The PMRA supports a tiered and flexible approach to information requirements and recognizes that the information needed to make a regulatory decision should be commensurate with the level of anticipated risks. As for all pest control products, the PMRA will require applicants to provide sufficient information to assess that a product has value and will not pose unacceptable risks to human health or the environment. Applicants are encouraged to make use of the presubmission consultation process described in Section 3.1 to help determine what information is needed.
Relevant data could be related to either pesticidal or other uses, and could include published literature or original studies. Where they exist, submission of regulatory reviews conducted in other countries is encouraged. In some cases, data requirements may be waived on the basis of a scientifically valid rationale. For example, a long history of exposure to humans or the environment could form the basis of a request to waive some data requirements, especially if the historical routes and levels of exposure are similar to what would result from the proposed uses of the product. Detailed guidance on waiver requests is provided in Appendix I.
Prior to initiating any original testing, applicants should consult the PMRA on proposed protocols, particularly those that may deviate from internationally recognized guidelines.
At any point during the PMRA assessment, additional information may be requested if the available information is inadequate or if potential risks are identified.
The applicant must provide enough information on both the technical grade active ingredient and the end-use product to characterize the product composition. The identity of any impurities of toxicological or environmental concern suspected to be present in a product must be disclosed regardless of concentration. For non-conventional products that contain a mixture of active components, the applicant may opt to only register one technical product comprised of all ingredients in the mixture, instead of registering each active component separately.
Toxicology information is required to assess the hazard of a product to human health. This information, combined with information on exposure, forms the basis of the human health risk assessment. Certain uses may require more supporting information than others. For example, a personal insect repellent may require significantly more toxicology information than a product that is not applied directly to the skin.
The applicant must provide sufficient toxicology information on the technical active ingredient and end-use formulated products to show that they pose low acute and chronic risks. Products must not be genotoxic, carcinogenic, neurotoxic or immunotoxic, cause reproductive or developmental effects, metabolize into compounds of toxicological concern or be anticipated to bioaccumulate. In addition, products should not have the potential to cause unintended adverse effects to companion animals.
An initial assessment of potential occupational and bystander exposure during and following application of a product will be based on the proposed use pattern and the draft labels. Information required includes:
The requirement for dietary exposure information depends on the toxicological profile of the product and its use. If a product is to be applied to food or feedstuff, the applicant must show that any anticipated residues of the parent compound or any metabolites will not pose a toxicological concern. Crop residue data will usually be required if residues of toxicological concern in excess of natural background levels are likely to occur on a consumable commodity.
The information required to assess potential risks to non-target aquatic and terrestrial organisms will primarily depend on the proposed use, which usually determines in which environmental media (soil, water, sediment, air) non-target organisms could be exposed. The applicant must provide information to show the product poses low acute risks to any non-target aquatic or terrestrial organisms likely to be exposed.
In the Pest Control Products Act, value of a pest control product means Athe product's actual or potential contribution to pest management, taking into account its conditions or proposed conditions of registration, and includes the product's:
The applicant must provide evidence that a product has value for the proposed uses claimed on the label. This could include information from experimental trials, published studies, scientific rationales, a product's use history in another jurisdiction and analysis of the product's potential benefits. In most cases, efficacy data requirements for non-conventional products will be less than for conventional pest control products and the establishment of a lowest effective rate will not be needed. The PMRA recognizes that some non-conventional products may not be as efficacious as conventional products and, if a product is not effective enough to support a standard use claim, a lower level claim such as "reduces damage, reduces annoyance, reduces innoculum, reduces populations, suppresses symptoms or may inhibit" may be acceptable. Applicants are encouraged to submit any information describing the value of the product as a pest management tool, in addition to its efficacy.
Products like personal insect repellents, sanitizers and pool bactericides, where the pests controlled may pose a concern to public health, may not be eligible for reduced value/efficacy data requirements or reduced use claims.
Applicants are encouraged to request a presubmission consultation with the Agency, particularly if they are not familiar with the Canadian regulatory system or need assistance in determining specific information requirements. The main objectives of a presubmission consultation are to determine the following before making an actual application for registration:
A presubmission consultation is also an opportunity to request guidance in building a successful submission package for a product. For example, draft labels for the technical grade and formulated product(s) are requirements for every submission, regardless of the type of use or application. Although labels vary in their complexity, they must clearly show how the product is to be used and for what purpose. The PMRA can provide tips to prospective applicants on creating product labels. A fully searchable database of registered labels is available on the Pesticides and Pest Management portion of Health Canada's website, which can be used as examples for creating a product label. An example of a draft label has also been included in this document (Appendix III).
Applicants can request a consultation through the presubmission webpage (http://www.hc-sc.gc.ca/cps-spc/pest/registrant-titulaire/pre-consult/index-eng.php) or by contacting the PMRA at firstname.lastname@example.org. An information package containing as much information as possible about the technical grade active ingredient, the product and the proposed uses should be submitted as the first step in the consultation. The information package must include a cover letter with the following information:
If applicable, the package should also include:
The PMRA's advice will be based on the information package that has been provided. If an applicant wishes, he/she may request a meeting to discuss the results of a presubmission consultation. This is generally scheduled two to three weeks after the PMRA's initial advice has been communicated to the applicant. During this meeting, the applicant may discuss his/her submission with scientific and technical staff at the PMRA about information requirements or administrative issues.
Subsequent to a presubmission consultation, the information requirements for the specified product(s) and use pattern will be communicated to the applicant. A copy of this consultation document must be enclosed with the submission to initiate the registration process. It is recommended to verify the validity of the information requirements if the application for registration is made later than the two year period following the closure of the presubmission consultation process as requirements may change.
If it is determined that the proposed product is not eligible for an evaluation under this directive, the applicant will be notified as soon as possible and referred to the conventional review stream.
Details on how to prepare a submission package to register a product can be found in Regulatory Directive DIR2006-05, Requirements for Submitting Data Index, Documents and Forms. All information requirements identified during the presubmission consultation must be addressed, using appropriate information from scientifically valid sources such as studies or requests for waivers based on scientific rationales. Only complete submissions will be considered for review by the Agency. If the applicant did not make use of the presubmission consultation process, the PMRA will assess eligibility for review under this directive early in the review process and will notify the applicant of any additional data requirements.
Due to the variability of composition and diverse conditions of use, it is anticipated that registration will continue to be the route most commonly used for non-conventional products. However, as with conventional pesticides, non-conventional products are eligible for exemption from registration for research purposes as described in Regulatory Directive DIR98 05, Chemical Pesticides Research Permit Guidelines, under Schedule II of the Pest Control Products Act, and for the Own-Use Import Program, subject to compliance with prescribed conditions.
The performance timeline for submission review of products under Regulatory Directive DIR2012-01, Guidelines for the Registration of Non-Conventional Pest Control Products will be similar to the timelines presented in Regulatory Directive DIR2002-02, The PMRA Initiative for Reduced-Risk Pesticides.
Some of the products reviewed under this directive will be eligible for fee exemption or reduced fee status as described in the PMRA's Guidance Document on Pest Control Product Cost Recovery Fees. The applicant is responsible for providing a written rationale as to why their product should be considered for a fee exemption or reduced fee status.
Toxicology data waiver requests must be science-based and should include supporting documentation. They can be based on one or more of several premises as outlined in the example below. All relevant toxicity information should be submitted, including Material Safety Data Sheets and Technical Bulletins.
Waiver Request Justification:
The waiver request is based on [one or more of] the following rationales:
Increased environmental exposure to the active ingredient, due to use of the end-use product, will be minimal: Describe levels of naturally occurring substance in environment/use site. Address whether it is ubiquitous in nature and provide information on its geographical distribution and sources; from where it has been isolated (for example, soil, plants/crops/vegetables/fruits, insects, streams, ponds, lakes, etc.). Describe its environmental fate and/or degradation rate and/or formation of metabolites and metabolite fate/degradation. Discuss the extent to which the proposed use pattern will increase the active ingredient above background levels and estimate the time it will take to return to background levels.
No evidence of toxicity and/or no adverse effects: Conduct an extensive literature search of key databases (for example, TOXLINE«, Biological Abstracts, CHEMTOX« [Hazardous and Regulated Chemicals Database]) on the active ingredient and its metabolites to ascertain whether there are any acute, short-term and chronic toxicity data available on humans and/or other mammals (for example, rodents). If little or no public data/information is available on the toxicity of the active ingredient to be registered, then data may be submitted on chemically equivalent or similar substances with an accompanying explanation why the surrogate data should be considered representative of the toxicological effects expected of the active ingredient.
Proposed label uses mitigate/eliminate human exposure: Discuss proposed label use sites (for example, outdoor food/non food, greenhouses, etc.) and rate/timing of application, application methods (for example, spray, dip, soil incorporation, ground boom, aerial, etc.) and their effects on limiting human exposure, if applicable. Address measures to minimize/eliminate direct exposure to humans (workers and bystanders), as well as whether timing of application precludes direct/indirect exposure to humans.
References Cited: Rationales should be supported by references. Cite references by number in brackets in order of mention in the text as if it were in a published technical journal article. Provide full references in this section at the end of the waiver request.
Environmental data waiver requests must be based on a scientific rationale and should include supporting documentation. Some examples are as follows:
Rationale: Toxicity to the non target organism or environmental fate can be described by surrogate data
Supporting documentation: Surrogate data (for example, bridging information based on a similar chemical) that describes potential environmental toxicity or fate of the proposed pesticide, and a rationale supporting the validity of extrapolating from the surrogate data to the proposed pesticide.
Rationale: Increase in non-target organism exposure to the active will be negligible
Supporting documentation: Describe levels of naturally-occurring substance in environment/use site. Give geographical distribution and sources. Has it been isolated from soil, plants, crops, vegetables, fruits, insects, streams, ponds or lakes? Describe environmental fate/degradation rate including formation of metabolites and their fate/degradation, if applicable.
Rationale: There is no evidence of toxicity or adverse effects to the non-target organism at relevant exposure levels, demonstrating a long history of safe exposure
Supporting documentation: For natural or existing substances that have a history of environmental exposure, a literature search demonstrating that there is no information indicating toxicity or adverse effects on the non-target organism can be submitted. Indicate which databases were searched and the search terms (year range, active name, synonyms, metabolites, etc.) The results or a summary of the results of the literature search should be submitted. Non-target organism exposure of natural/existing substance must also be estimated and compared to the proposed use.
Rationale: Proposed label uses mitigate or eliminate exposure
Supporting documentation: Describe how method of application minimizes direct exposure to the non-target organism. Describe how timing of application precludes direct or indirect exposure to the non-target organism. Discuss proposed label use sites and rate/timing of application, application methods and their effects on limiting drift/runoff, if applicable. Give degradation rates of active ingredient in days/weeks/months, if available. Would runoff or overspray result in effects not seen from naturally occurring levels?
Basic label requirements are outlined below. For more detailed information on the preparation of product labels, refer to the list of references under Policies, Guidelines and Codes of Practice, Labeling of Products, on the Health Canada website: http://www.hc-sc.gc.ca/cps-spc/pest/protect-proteger/publi-regist/codes-eng.php.
Note: For domestic class products of very small size, points 5, 6, 7, 8 and above can appear on the secondary display panel.
NOTICE TO USER: This pest control product is to be used only in accordance with the directions on the label. It is an offence under the Pest Control Products Act to use this product in a way that is inconsistent with the directions on the label. The user assumes the risk to persons or property that arises from any such use of this product.
DOMESTIC USE: For use against dandelions in lawns.
DIRECTIONS: Treat when plants are growing. Do not mix with any other materials. Spray foliage at rate of 100 mL/m2. Spray uniformly over all plant surfaces to be treated.
PRECAUTIONS: KEEP OUT OF REACH OF CHILDREN. Avoid contact with skin, eyes and clothing. Wash with soap and water after use.
Take container, label or product name and Pest Control Product Registration Number with you when seeking medical attention.
TOXICOLOGICAL INFORMATION: Treat symptomatically.
STORAGE: Store at temperatures between 0°C and 15°C. Store container upright and keep tightly closed when not in use.
DISPOSAL: Do not reuse empty container. Dispose of empty container with household garbage.
Note: The above documents may be revised in the future. When a revised or final document is issued, the title may be slightly modified and there will be a new reference number. Applicants should contact the PMRA or refer to the Pesticides and Pest Management portion of Health Canada's website at healthcanada.gc.ca/pmra to determine whether any of the listed references have been superseded by more recent or final versions.